An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.

In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and ...

In an interview with Pharmaceutical Executive, Barry Quart, CEO, Connect Biopharma, discussed his decision to join the company to advance rademikibart—a novel biologic therapy showing promise in ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

The impact of Alzheimer’s disease is a prominent one, as it impacts an estimated 6.9 million US residents ages 65 and older. 1 This makes it the most common form of dementia, while other forms include ...

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...